Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06263998
Status:
RECRUITING
Last Update Posted:
2024-02-16
First Post:
2024-01-26
Brief Title:
Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops
Sponsor:
Huons Co Ltd
Organization:
Huons Co Ltd
Study Overview
Official Title:
A Randomized Double-blind Parallel Placebo-Controlled Single and Multiple Ascending Dose Phase 1 Clinical Study to Assess the Safety and Local Tolerance Pharmacokinetics After Application of NCP112 Eye Drop in Healthy Subjects
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective is to evaluate the safety local tolerability and pharmacokinetics of NCP112 eye drops through single and multiple dose-escalation ocular administrations in healthy adults
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None